unmet needs in ptcl: improving frontline therapy and personalizing treatment
Published 1 month ago • 111 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:40
major unmet needs in the mcl patient population
-
1:32
blast-phase mpns: a major unmet need in the field
-
1:20
unmet needs in mpn treatment
-
1:54
therapeutic approaches in the front-line for patients with ptcl
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
0:51
the need for novel agents for the treatment of ptcl
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
55:54
management of peripheral t-cell lymphoma
-
7:18
how might luspatercept benefit patients with myelofibrosis?
-
6:24
polycythemia vera: latest updates for patients & caregivers in 2022 | dr. ruben mesa | blood cancer
-
1:13
the unmet needs and future of cmml treatment
-
1:36
novel therapeutic regimens being explored in ptcl
-
1:58
unmet needs in sr-agvhd and tr-agvhd
-
3:11
unmet needs in bpdcn and strategies to optimize care for patients
-
1:39
insights into the main subtypes of ptcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:15
key unmet needs in t-cell lymphoma: developing novel therapeutic strategies to improve outcomes
-
2:17
the unmet needs of patients who have visual impairment as a consequence of scd
-
2:39
treating and managing blast-phase mpns: a major unmet need
-
1:49
pid unmet needs: awareness, testing and diagnosis
-
2:02
unmet needs in high-risk mds and future therapeutic strategies